Sinocrom 1% syringe, 2 ml

Synocrom replaces the synovial fluid, the main function of which is to lubricate the cartilage of the joint. In this way, the drug improves joint mobility, prevents its abrasion and thinning, and relieves pain and stiffness that occur in the affected joints during movement.

In addition to improving significantly the condition of the tissues of the affected joints, the product also stimulates processes in the cartilage tissue responsible for the formation of new synovial fluid and the production of its own hyaluronate.

The use of Sinocrom helps restore the disturbed balance in the cartilage tissues of the joints and thus prevents the development of arthrosis. In addition, reviews of Sinocrom indicate that the use of this drug can significantly reduce the need for non-steroidal anti-inflammatory drugs.

Indications

For pain and limited mobility as a result of degenerative or post-traumatic changes in joints containing synovial fluid.

Active ingredient

Composition

1 syringe (2 ml) contains:

The active ingredient:

20 mg of sodium hyaluronate with a molecular weight of ~1.6 million Dalton,

Associates:

sodium chloride,

sodium monohydrogen phosphate,

citric acid,

water for injection.

How to take, the dosage

The drug is injected by specialist physicians under aseptic conditions. The prepared syringe is removed from the sterile case, the rubber cap is removed from the adapter of the Luer system with a slight twist, then the corresponding sterile needle is put on, which is also fixed with a slight twist (the injection needle is not included in the delivery set). The injection site is treated with a disinfectant containing alcohol.

The Synocrom drug is injected precisely into the joint cavity according to standard techniques, taking into account the anatomical features. The injection of the drug into the joint cavity should be discontinued if pain occurs during the injection.

The drug shall not be stored unused to the end. The course of treatment with Synocrom is 3-5 injections with an interval of one week between injections. Treatment of several joints at the same time is possible. The course of treatment consisting of 5 injections can be effective over 6 months (depending on the severity of the disease). Repeated courses of treatment are allowed.

Interaction

There is currently no information on the incompatibility of Sinocrom with other solutions for intra-articular administration.

Do not use disinfectants containing quaternary ammonium salts because hyaluronic acid precipitates in the presence of these substances.

Special Instructions

Synocrom is intended for intraarticular administration only.

The use of Synocrom has not been investigated in pregnant women and children under 18 years of age.

Synocrom should be stored out of the reach of children.

Synocrom is intended for single use only. Re-sterilization is not allowed.

Do not use a syringe from an open and/or damaged sterile package. Do not use the syringe with an open or damaged sterile syringe cap.
Do not use after the expiration date.

Contraindications

Synocrom cannot be used in patients with hypersensitivity to one of the components of the drug.

In view of intraarticular administration of the drug, patients with bacterial arthritis should refrain from treatment with this drug to avoid possible complications.

The treating physician must be aware of all immunologic and other possible effects of biologic drugs.

Side effects

In extremely rare cases patients using Sinocrom may experience local symptoms (pain, fever, redness and swelling, increased exudate in the joint cavity).

In order to avoid such manifestations or if they appear it is recommended to relieve the affected joint and put an ice-pack on the joint for 5-10 minutes. In case of pronounced manifestations accompanied by severe pain, the solution should be removed from the affected joint.

There have been isolated cases of allergic reactions (itching, rash, urticaria) and anaphylactic reactions.

Similarities